| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/11/2006 | US20060099239 Dietary supplement for promoting removal of heavy metals from the body |
| 05/11/2006 | US20060099227 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyethyl Starch |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099216 Peptide delivery |
| 05/11/2006 | US20060099213 Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 05/11/2006 | US20060099212 treating or preventing a tumor necrosis factor-mediated disease by co-administering methotrexate and a TNF alpha antagonist |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099200 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 05/11/2006 | US20060099199 Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
| 05/11/2006 | US20060099197 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/11/2006 | US20060099194 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 05/11/2006 | US20060099186 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 05/11/2006 | US20060099185 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 05/11/2006 | US20060099184 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 05/11/2006 | US20060099183 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft |
| 05/11/2006 | US20060099181 Viral vectors having reduced virulence |
| 05/11/2006 | US20060099179 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy |
| 05/11/2006 | US20060099176 Administering system for interferon, includes a first step for detecting the number of interferon receptors on a surface of the cell, a second step for administering interferon being prepared so that an interferon dosage is determined according to number of IFN receptors on the cell surface |
| 05/11/2006 | US20060099175 exhibiting IFNG (interferon gamma) receptor binding activity, comprising peptides having replacements in the amino acid sequences, useful in therapy, in particular for the treatment of respiratory system disorders such as idiopathic pulmonary fibrosis |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099173 Topical skin care composition |
| 05/11/2006 | US20060099172 Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of prophylaxis and treatment of avian influenza |
| 05/11/2006 | US20060099170 Compositions for inducing increased levels of beta-chemokines and methods of use therefor |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | DE102004053410A1 Cyclische Nonadepsipeptidamide Cyclic Nonadepsipeptidamide |
| 05/11/2006 | DE102004053407A1 Acylierte Nonadepsipeptide II Acylated nonadepsipeptides II |
| 05/11/2006 | DE10055742B4 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/11/2006 | CA2627187A1 Arthrospira-based compositions and uses thereof |
| 05/11/2006 | CA2602070A1 Cyclic nonapeptide amides |
| 05/11/2006 | CA2586389A1 Modified growth hormones |
| 05/11/2006 | CA2586254A1 Therapeutic agent for neuropathic pain |
| 05/11/2006 | CA2586081A1 Use of a bacterial vector comprising a saccharide inducible promoter as an expression system |
| 05/11/2006 | CA2586064A1 Prodrugs of ribavirin with improved hepatic delivery |
| 05/11/2006 | CA2586033A1 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | CA2585817A1 Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| 05/11/2006 | CA2585776A1 Combination cancer immunotherapy with co-stimulatory molecules |
| 05/11/2006 | CA2585758A1 Remodeling and glycopegylation of fibroblast growth factor (fgf) |
| 05/11/2006 | CA2585647A1 Dose forms comprising vx-950 and their dosage regimen |
| 05/11/2006 | CA2585621A1 Improved quenching methods for red blood cell inactivation process |
| 05/11/2006 | CA2585482A1 Treatment of short bowel syndrome patients with colon-in-continuity |
| 05/11/2006 | CA2583570A1 Combination comprising zd6474 and an antiandrogen |
| 05/11/2006 | CA2582048A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
| 05/11/2006 | CA2578854A1 Spontaneously dispersible pharmaceutical compositions |
| 05/11/2006 | CA2566535A1 Ige-retargeting, function-altering molecules (erfam) for treatment of allergic diseases |
| 05/10/2006 | EP1655605A2 Treatment and diagnosis of cancer |
| 05/10/2006 | EP1655382A2 Colon specific gene and protein |
| 05/10/2006 | EP1655369A1 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 05/10/2006 | EP1655368A1 Vascular endothelial cell growth factor variants and uses thereof |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655308A1 Adducts of soluble ovalbumin with trivalent iron polyalcohol complexes and method to produce them |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655292A1 Preventive or therapeutic composition for viral infectious disease |
| 05/10/2006 | EP1655039A2 Immunoliposomes that optimize internalization into target cells |
| 05/10/2006 | EP1655036A1 Method for treating oncological diseases |
| 05/10/2006 | EP1655035A1 Treatment of heart failure with CSF-1 |
| 05/10/2006 | EP1655033A1 Nucleosides with anti-hepatitis B virus activity |
| 05/10/2006 | EP1655023A1 Botulinum toxin implat |
| 05/10/2006 | EP1655015A1 Hair regenerator |
| 05/10/2006 | EP1654380A2 Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
| 05/10/2006 | EP1654378A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 05/10/2006 | EP1654352A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 05/10/2006 | EP1654285A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 05/10/2006 | EP1654283A1 Improved method of purifying tfpi and tfpi analogs |
| 05/10/2006 | EP1654279A2 Adipocyte complement related protein zacrp12 |
| 05/10/2006 | EP1654261A1 Hepatitis c inhibitor compounds |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654036A1 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 05/10/2006 | EP1654015A2 Decellularized bone marrow extracellular matrix |
| 05/10/2006 | EP1654004A2 Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides |
| 05/10/2006 | EP1653996A2 Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
| 05/10/2006 | EP1653995A1 Interleukin-20 for treating and diagnosing conditions associated with neovascularisation |
| 05/10/2006 | EP1653994A2 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 05/10/2006 | EP1653993A1 Use of chemokines, and pharmaceutical preparations containing the same |
| 05/10/2006 | EP1653992A1 Use of a vegf antagonist in combination with radiation therapy |
| 05/10/2006 | EP1653991A2 Conjugates of a polymer and a protein linked by an oxime linking group |
| 05/10/2006 | EP1653990A1 Use of polypeptides of the cupredoxin family in cancer therapy |
| 05/10/2006 | EP1653989A2 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 05/10/2006 | EP1653988A2 Leukocyte internalized peptide-drug conjugates |
| 05/10/2006 | EP1653987A2 Host defense factor x (hdfx) |
| 05/10/2006 | EP1653986A2 Treatment of cancers expressing p95 erbb2 |
| 05/10/2006 | EP1653985A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 05/10/2006 | EP1653984A2 Drug delivery systems for tumor targeting by ngr-molecules and uses thereof |
| 05/10/2006 | EP1653981A1 Fish protein hydrolyzate |
| 05/10/2006 | EP1653970A2 Gsk-3 inhibitors and uses thereof |
| 05/10/2006 | EP1653912A2 Vaccine immunotherapy for immune suppressed patients |
| 05/10/2006 | EP1653844A2 Prion-specific peptide reagents |
| 05/10/2006 | EP1509598A4 Induction of insulin expression |
| 05/10/2006 | EP1495006A4 Inhibitors of glycinamide ribonucleotide transformylase |
| 05/10/2006 | EP1478383A4 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 05/10/2006 | EP1441742A4 Axon repair |
| 05/10/2006 | EP1320609B1 Isolated peptides which bind to hla-c molecules and uses thereof |
| 05/10/2006 | EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1290012B1 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 05/10/2006 | EP1282641B1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 05/10/2006 | EP1254159B1 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1161256B1 Use of nerve growth factor for the manufacture of a medicament for therapy of intraocular tissue pathologies |
| 05/10/2006 | EP1150696B1 Genetically engineered herpes virus for the treatment of tumours |